SARS-CoV-2 Omicron: reduction of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
暂无分享,去创建一个
D. Khoury | D. Cromer | S. Turville | A. Ospina Stella | J. Henry | D. Christ | W. Rawlinson | P. Schofield | S. Amatayakul-Chantler | A. Aggarwal | D. Darley | Y. Lu | A. Kelleher | G. Matthews | J. Jackson | G. Walker | A. Hoppe | C. Fichter | V. Mathivanan | O. Mazigi | C. Foster | M. Davenport | N. Roth | A. Akerman | V. Milogiannakis | S. McAllery | G. Coppola | M. Munier | H. Jaeck | D. Langles